Moderna to Pay Up to $2.25B to Settle Patent Suit Over Covid-19 Vaccine Technology

Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid nanoparticle technology for mRNA delivery in infectious disease vaccines. If Moderna’s full financial payout to the companies is reached, it would rank among the largest disclosed patent settlements in biopharmaceutical industry history. The post Moderna to Pay Up…

Read More

Oren Nissim, Brook-ai – Figuring out RPM

Oren Nissim is the CEO of Brook-ai which is been making some waves in the remote care space. Their goals is to use remote patient monitoring to help providers reduce readmissions, and help patients stay on their care plans. For example they get more then 50% of their populations into hypertension control within 10 weeks,…

Read More